Follow us on...


Search News Archives
Events
«  »
SMTWTFS
 123456
78910111213
14151617181920
21222324252627
28293031 

The European Biopolymer Summit


MediSens Conference 2018


3rd International Conference on Enzymology & Molecular Biology


Forensics Europe Expo


The European Drug Safety Summit 2018


 

Media Partners


 

 


Subscibe to our YouTube channel

 

 

E-Newsletter Month  
Lab Bulletin Monthly Update December view archive
Microscopy & Image Analysis December view archive
Separation Science December view archive
Weekly Update January (3) view archive

For further information or to sign up to receive any of our E-Newsletters click here


Leading French Lab Uses Skeletal Muscle Differentiation Kit to Study Duchenne Myopathy

publication date: Aug 15, 2017
 | 
author/source: AMSBIO

metabolic disorders

AMSBIO reports on an independent evaluation and use by I-Stem (Corbeil-Essonnes, France) of the Skeletal Muscle Differentiation kit - a cell culture media system to differentiate human stem cells into functional myotubes.

I-Stem was formed in 2005 through a collaboration between Inserm, the French National Institute of Health and Medical Research, and AFM-Telethon the French Association against Myopathies. I-Stem is the largest French laboratory for research and development dedicated to human pluripotent stem cells. The objectives of the I-Stem muscular disease team are to explore and validate the potential of pluripotent stem cells and their differentiated progenies to design new therapeutic strategies for muscles diseases.

The potential to differentiate stem cells into specific cell types is revolutionizing life sciences, from new methods of studying developmental biology and novel approaches to producing accurate disease models to techniques to help drug discovery and toxicity testing.

Until recently, methods of studying muscular disease and metabolic disorders and potential therapies were dependent on invasive muscle biopsies to produce limited batches of primary cells. For many years, researchers looked for a simple protocol to obtain skeletal muscle cells from pluripotent stem cells. The Skeletal Muscle Differentiation kit offers an efficient method to differentiate human stem cells into skeletal muscle cells that demonstrate disease-specific phenotypes.

Emmanuelle Massouridès, a research engineer within the muscular disease team led by Christian Pinset at I-Stem commented "Following the simple 3-step process of media changes and cell passaging we were able to reliably obtain a homogenous population of skeletal muscle precursor cells in only 17 to 21 days from human induced pluripotent stem cells. Using these precursors we have been able to differentiate and form myotubes in 8 days with just a simple switch of medium". Dr. Massouridès added "This new protocol allows easy scale up of myoblast production by automation, cell modelling and high throughput screening. In our case, the Skeletal Muscle Differentiation protocol has given us the opportunity to study the onset of Duchenne myopathy in a dish and to decipher roles of Dystrophin toward different stages of muscle lineage differentiation."

The Skeletal Muscle Differentiation kit from AMSBIO offers researchers a unique tool to rapidly differentiate donor stems into functional myotubes in a reproducible fashion. Tested on a wide range of human embryonic and induced pluripotent stem cell lines the new kit follows a simple 3-step process of media changes and cell passaging. Eliminating the need for cell sorting or transfection of myogenic transcription factors, the 3-step protocol generates a highly pure population of approximately 70 per cent skeletal muscle myotubes in weeks.

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO can draw upon in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. Widely acknowledged as an expert in cell culture, AMSBIO partners with clients in tailoring cell systems to enhance organoid and spheroid type screening outcomes from a technological and cost-effective perspective.


more about AMSBIO


more news from AMSBIO


 

 

 




Can't find what you are looking for?


Search by company, product or location

Company Name:

Location:

Product:



Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have a product enquiry, please contact the supplier directly.


Lab Bulletin is published by newleaf marketing communications ltd

Promotions